Liver Enzyme Concentrations Research Articles

Evaluation of oclacitinib maleate and prednisolone combined therapy for the control of atopic dermatitis in dogs: A controlled clinical trial.

Canine atopic dermatitis (cAD) is a chronic inflammatory and pruritic dermatopathy requiring a multimodal therapeutic approach. To assess the effectiveness, safety and cost of oclacitinib and prednisolone treatment in dogs with AD. Twenty-three client-owned dogs with cAD. Dogs were randomly assigned to one of two groups: Group 1 received prednisolone (0.5 mg/kg every 24 h) for 7 days, then oclacitinib (0.5 mg/kg) and prednisolone (0.5 mg/kg), were administered alternately with a 1 day pause between each drug, for 7 additional weeks. Group 2 received oclacitinib (0.5 mg/kg every 12 h for 14 days, then every 24 h) for 8 weeks. Assessments included the Canine Atopic Dermatitis Extent and Severity Index, 4th iteration (CADESI-04) and pruritus Visual Analog Scale (PVAS) on Day (D)0, D7, D14, D30, D45 and D60. Both groups showed significant CADESI and PVAS reductions on D7 (p < 0.001). From D14 to D60, mean scores remained stable compared to D7, with no significant differences between groups. Adverse events included two dogs with polyuria and polydipsia, and three with polyphagia in Group 1, all of which resolved by D14. In Group 2, one dog experienced polyphagia, and two had self-limiting vomiting. Three dogs in Group 1 and one dog in Group 2 had mild increases in liver enzyme concentrations. The combined protocol was effective and safe for managing itch and inflammation over a 60 day period. It had a 73.3% lower cost compared to oclacitinib alone.

Alcohol-induced liver injury is mediated via α4-containing nicotinic acetylcholine receptors expressed in hepatocytes.

Our previous study demonstrated that alcohol induced the expression of the α4 subunit of nicotinic acetylcholine receptors (nAChRs) in the livers of wild type mice (WT), and that whole-body α4 nAChR knockout mice (α4KO) showed protection against alcohol-induced steatosis, inflammation, and injury. Based on these findings, we hypothesized that hepatocyte-specific α4 nAChRs may directly contribute to the detrimental effects of alcohol on the liver. Hepatocyte-specific α4 knockout mice (α4HepKO) were generated, and the absence of α4 nAChR was confirmed through PCR of genomic DNA. Female WT and α4HepKO mice were exposed to alcohol in the NIAAA chronic + binge model. After 10 days on the Lieber-DeCarli liquid diet containing 5% (vol/vol) alcohol or isocaloric maltose-dextrin, the mice were gavaged with a single dose of alcohol or isocaloric maltose-dextrin. The mice were euthanized 9 h later and their organs harvested. Additionally, hepatocytes were isolated from WT, α4HepKO, α4floxed, and α4KO mice and exposed to 80 mM alcohol invitro for 24 h. Steatosis, inflammation, and cell injury were assessed in both liver and isolated hepatocytes. In WT mice, alcohol exposure resulted in hepatic steatosis, inflammation, and injury as evidenced by increased liver triglycerides, neutrophil infiltration, and serum concentrations of liver enzymes. All of these responses were markedly lower in α4HepKO mice. mRNA expression of genes involved in lipogenesis (Srebf1, Fasn, and Dgat2) and inflammation (TNFα, Cxcl5, Cxcl1, and Serpine1) were increased in the livers of WT mice exposed to alcohol invivo and in WT hepatocytes exposed to alcohol invitro. These changes were not observed in liver or hepatocytes from mice lacking α4 nAChRs. α4 nAChRs expressed in hepatocytes mediate alcohol-associated hepatoxicity. Therefore, the development of therapeutic strategies targeting hepatocyte α4-containing nAChRs could help reduce the burden of ALD.

IRG1/Itaconate inhibits hepatic stellate cells ferroptosis and attenuates TAA-induced liver fibrosis by regulating SLC39A14 expression.

This study aimed to elucidate the protective roles of Immune Response Gene-1 (IRG1) and exogenous itaconate in murine models of hepatic fibrosis and to delineate the underlying mechanistic pathways using both wild-type and IRG1-deficient (IRG1-/-) mice. Primary murine stellate cells (mHSC) and bone marrow-derived macrophages (BMDM) were isolated and cocultured. Hepatocellular fibrosis was induced in vitro using Transforming Growth Factor-beta (TGF-β) to evaluate the protective efficacy of IRG1/itaconate. Histopathological damage in the hepatic tissues was assessed using Hematoxylin and Eosin (H&E), Masson's trichrome, and Sirius red staining, followed by hepatic fibrosis scoring. The levels of released inflammatory cytokines were quantified using enzyme-linked immunosorbent assay (ELISA) kits. Immunohistochemistry was used to detect 4-Hydroxynonenal (4-HNE) levels and Perls staining was used to assess ferroptosis. RNA sequencing and gene enrichment analyses were performed to identify implicated molecular entities and signaling pathways. IRG1 and SLC39A14 knockdown and overexpression cell lines were generated. Quantitative real-time PCR (qRT-PCR) and western blotting (WB) were used to measure the mRNA and protein expression levels in hepatic tissues and cells. Kits were used to assess reactive oxygen species (ROS) and malondialdehyde (MDA) levels, and the concentrations of liver enzymes, iron, GSH, and GSSG within hepatic tissues and cells.4-octyl itaconate (4-OI) significantly attenuated the histopathological damage in hepatic tissues, preserved the normal hepatic function, effectively reduced the release of inflammatory cytokines, and mitigated oxidative stress markers such as ROS and MDA in Thioacetamide (TAA)-induced fibrotic mice. Notably, this study is the first to reveal the pivotal role of SLC39A14 in the pathogenesis of hepatic fibrosis in murine models and elucidate how IRG1/itaconate mediates downstream ferroptosis-related signaling pathways by targeting SLC39A14, thereby inhibiting ferroptosis-induced hepatic fibrosis. IRG1/itaconate can alleviate the TAA-induced hepatic fibrosis in mice by regulating the expression of SLC39A14, consequently suppressing hepatic stellate cell ferroptosis.

Supplementation of lysophospholipids in calf starter: effects on growth performance, blood metabolites, health, and ruminal ammonia nitrogen concentration

Supplementation of lysophospholipids in calf starter: effects on growth performance, blood metabolites, health, and ruminal ammonia nitrogen concentration

Chronic metabolic effects of novel gut-oriented small-molecule GPR119 agonists in diet-induced obese mice

The pharmacological activation of G-protein coupled receptor-119 (GPR119) modulates glucose, energy, and hepatic lipid homeostasis in type-2 diabetes (T2D). We developed synthetic small-molecule GPR119 agonists targeting gastrointestinal receptors. This study investigates the chronic metabolic effects of lead candidates, ps297 and ps318, individually and in combination with sitagliptin, a dipeptidyl peptidase-IV (DPP-IV) inhibitor, in high-fat diet (HFD)-induced obese (DIO) mice. In a 10-week dose-escalation protocol, DIO mice were orally treated with the investigational agents alone (10-90 mg/kg/day) and in combination with sitagliptin (20 mg/kg/day). Weekly body weight, food intake, and random blood glucose levels were monitored during the treatment phase. Post-treatment, an intraperitoneal glucose tolerance test (ipGTT), estimation of plasma biomarkers and haematological assessment were conducted. The treatment's effect on hepatic steatosis was studied by estimating liver biomarkers and histological examinations. Ten-week sitagliptin combination therapy with the investigational entities restored incretins, insulin, and other metabolic hormonal secretions, accompanied by improved glucose homeostasis and retarded weight gain. Interestingly, monotherapy with investigational agents improved liver health by reducing liver weight, liver enzymes, and inflammation. Hepatic effects were further enhanced by co-administration of sitagliptin, evident by amelioration in hepatic steatosis endpoints such as liver weight, plasma liver enzyme concentrations, hepatic triglycerides (TG), total cholesterol (CHO), hydroxyproline content, and cytokine levels. Histopathological investigations confirmed regression in hepatic steatosis in the combination groups. These findings demonstrate the therapeutic potential of novel gut-oriented GPR119 agonists in combination with a DPP-IV inhibitor to ameliorate metabolic dysfunction-associated steatohepatitis (MASH), warranting further mechanistic investigations.

Chemical and biological study on the effect of yoghurt on most common consumed ready meat products

Basterma is characterized as fresh non cooked and manufactured under the addition of salt, phosphate, nitrite, ascorbic acid, sugars, and different seasoning(1). Sausages are very common and popular processed meat products manufactured from lower-value trimmed meat to produce a higher-value product(2). Basterma is fermented during the partially drying process under climatic conditions(3,4). Nitrates and nitrites are chemicals that can be found naturally in our food, water and in plant nutrients. Nitrites cause a color reaction in the meat and add an appealing pink color to cooked products(5). Nitrite prevents the growth of a harmful bacterium called Clostridium botulinum and other spoilage bacteria(6). This study was to estimate nitrite and nitrate in basterma and sausage and the effects of yoghurt in lowering the side effect of nitrite and nitrate at heavy consumption of some ready-made meat products.The ready-made meat products and yoghurt were bought from different supermarkets in Riyadh/KSA. Thirty-five male albino rats, weighing 110 ± 6 g was provided from experimental animal’s center in Medicine collage of KSU in Riyadh. The experimental diet formed from basal diet but basterma and sausage were added to basal diet instead of casein. The nitrite and nitrate contents were determined in experimental readymade-meat products immediately after purchase in triplicate by rapid method of improved accuracy according to Follett and Ratcliff method. Rats fed on basal diet for a week as adaptation period in wire cages under the normal laboratory conditions. Food intake was calculated daily, and the body weight gain was recorded weekly. Collected data are expressed as mean ± SE. Statistical analysis was done by using analysis of variance (ANOVA) followed by student’s t-test and P values of 5% and less were significant.The results of ALT, AST, ALP and γ GT of the experimental rat groups noticed that a non-significant higher in values of AST, AST and γ GT and a non-significant lower in values ALT and ALP compared to rat group which fed on basterma. Rat groups which fed on basterma with yoghurt, sausage with yoghurt, and both basterma and sausage with yoghurt showed a significant decrease in liver enzymes concentration in comparison with rat groups which fed on either basterma or sausage but showed non-significant difference among these groups. Also, results presented a significant decrease in creatinine, urea, and uric acid concentration in comparison with rat groups which fed on either basterma or sausage. Likewise for the results of total protein, albumin, and globulin for the same rat groups.It can be recommended from this study that heavy meat products consumer should consume yoghurt to lower side effects of meat preservative as nitrite and nitrate.

Investigating the postprandial metabolic and inflammatory phenotypes of healthy subjects and patients with metabolic dysfunction-associated steatotic liver disease and metabolic-dysfunction associated steatohepatitis to understand disease progression

Metabolic dysfunction-associated steatotic liver disease (MASLD), considered as the hepatic component of the metabolic syndrome, is the leading cause of chronic liver disease around the world(1). The MASLD disease spectrum begins with isolated steatosis. A subset of patients will develop metabolic dysfunction-associated steatohepatitis (MASH) which is characterized by steatosis and inflammation, resulting in hepatocyte injury with or without fibrosis. MASH is regarded as a progressive phenotype, as it can advance to cirrhosis and subsequently to hepatocellular carcinoma(2). Compared with fasting measurements alone, postprandial responses to nutrient challenges offer a greater insight into the phenotypic heterogeneity that occurs across health and disease(3). To better understand the phenotypes that occur across the spectrum of MASLD, we have characterized the postprandial metabolic and inflammatory responses to different dietary challenges in healthy individuals and patients with MASLD and MASH.10 healthy individuals, 18 patients with MASLD, and 15 with MASH were recruited. Body composition was assessed using bioelectrical impedance analysis (Tanita). Liver fat and stiffness were measured by FibroScan in patients only. All participants completed a high fat mixed meal challenge containing 655kcals, 46g fat, 33g saturated fat, 50g carbohydrates, 45g sugar, and 10g protein. Patients with MASLD and MASH also completed a high-fructose challenge containing 400kcals, 75g fructose and 25g glucose. Fasting and postprandial blood samples were drawn at each challenge at 0, 30, 60, 90, 120, 180, 240 and 360-minutes. Glucose was measured in whole blood using a HemoCue Glucose 201+ analyzer. Serum insulin and plasma IL-6 and CRP will be measured by ELISA. Plasma triglycerides, non-esterified fatty acids (NEFA), and glycerol will be measured by colorimetric assay.Bodyweight (p = 0.0247), BMI (p = 0.0448), and hip circumference (p = 0.0237) were greater in MASH vs MASLD. Healthy participants had significantly lower bodyweight, BMI, and waist and hip circumferences vs both MASLD and MASH (p&lt;0.0001 for each variable). Liver fat was similar between MASLD and MASH, whereas liver stiffness was greater in MASH (p&lt;0.0001). Alanine transaminase (ALT) was increased in MASH vs MASLD (p = 0.0408), while concentrations of other liver enzymes were similar between groups. Total cholesterol (p = 0.0492) and LDL-cholesterol (p = 0.0197) were also higher in MASH vs MASLD, but there was no difference in triglyceride concentrations or HDL-cholesterol. There was a significant impact of group on glucose response to the HFMM (p = 0.0321), and glucose responses varied between the 3 groups across different time points (p&lt;0.0001).The HFMM, which is more representative of a typical meal, revealed glucose intolerance in MASLD and MASH which was also greater in MASLD. Analysis of the full cohort will enable greater characterization of the phenotypes that occur across the spectrum of MASLD.

A Physiological Study of the Effect of Bee Pollen on Albino Rats Induced Hypothyroidism

The current study aimed to evaluate the therapeutic role of bee pollen (BP) in reducing the harmful effects resulting from hypothyroidism compared to the drug thyroxine on some physiological indicators and improving their levels, which included weight gain (gm), hormone level (T3, T4, TSH), level TPO, cholesterol levels, HDL, LDL, VLDL, and liver enzymes ALT, AST, Hypothyroidism was induced in (24) male rats using the drug carbimazole (CBZ) Which lasted for (15) days at 30 mg/kg of body weight. A random sample was chosen to confirm the occurrence of hypothyroidism, as the results of examining blood samples that were drawn from the animals showed a high concentration of the TSH hormone and Low concentrations of thyroid hormones in the serum compared to the negative control., and this indicates the occurrence of hypothyroidism. Then the animals in which hypothyroidism was induced were separated into 3 experimental collections in addition to the control group and a fifth group. Each group consists of (8) animals. The dosing period lasted thirty days orally. The negative control group, G1, was provided with a diet and water freely. G2 was continued to be dosed with the drug (CBZ) at a concentration of 30 mg/kg of body weight. G3 was continued to be dosed with the drug (CBZ) at a concentration of 30 mg/kg and solution (BP). At a concentration of 200 mg/kg body weight, G4 was dosed with levothyroxine at a concentration of 20 mg/kg body weight, while G5 was dosed with BP solution only at a concentration of 200 mg/kg body weight. At the end of the experiment, the animals were sacrificed and blood samples were obtained. The results were less than 0.05 in group G2 in body weight, the concentration of thyroid hormones T3 and T4, and the concentration of TPO and HDL, and a significant increase (P&lt;0.05) in the concentration of TSH, Cholesterol, LDL, and VLDL, respectively, with an increase in the concentration of liver enzymes. AST and ALT compared to the control group. As for the G3 and G4 groups, the result appeared an original increase a total body weight and the concentration of the hormones T3, T4, and the TPO enzyme, a noticeable improvement in the lipid profile, and a low level of the ALT enzyme and the and thyroid-stimulating hormone compared to the G2 group. As for the group G5 has witnessed an increase in T4 concentration and a decrease in ALT concentration and body weight, and the concentrations of T3, TSH, and TPO are closer to control. We conclude from the current study that BP has a role in reducing the effects of hypothyroidism, increasing weight gain, and improving the lipid profile and the level of ALT liver enzymes. AST and Thyroid peroxidase (TPO) level.

Hepatoprotective Effect of Corn Silk Extract on Carbonated Alcoholic Herbal Beverages Induced Hepatoxicity in Adult Wistar Rats

Corn silk is the long shiny fibers at the top of an ordinary ear of corn (Zea mays). Corn silk contains phytochemicals of medical benefit such as flavonoids compounds which act as antioxidant agents and has been widely reported possess hepatoprotective effect. The objective of this paper is to evaluate the hepatoprotective effect of corn silk extract on carbonated alcoholic herbal beverages (CAHB) induced hepatoxicity in adult Wistar rats. A total of forty five adult Wistar rats weighing between 200g and 250g were randomly assigned into nine groups of five rats each in a group. Group A was the normal control group (no CAHB administration). Groups B, C, D, E, F, G, H and I were the CAHB intoxicated groups and treated with corn silk extract at different doses. After administering a carbonated alcoholic herbal beverage, there was a substantial increase (p≤0.05) in the mean concentration of liver enzymes (ALP, ALT, ALT), total bilirubin, and direct bilirubin. While those characteristics reversed to values similar to the control after being treated with varying doses of corn silk extract The oxidative stress parameter (SOD, GPX, Catalase, MDA) shown significant increase in group. Histological examination of the liver revealed infiltrate of inflammatory cells, vascular ulceration, periportal infiltration of inflammatory cell, and vascular congestion in a group treated with carbonated alcoholic herbal beverages (CAHB). The only group exhibiting normal hepatocyte morphology and kupffer cell activity was the one administered 200 mg/kg of maize silk extract. Group D showed a similar and more powerful hepatic architecture after receiving only 600 mg/kg of maize silk extract. The hepatoprotective and anti- oxidative effects of corn silk extract were confirmed by the treatment groups (200 mg/kg and 600 mg/kg), which displayed normal hepatocytes with minor vascular congestion, respectively. Corn silk administration lowers a number of the harmful effects of in vivo carbonated alcoholic herbal beverage administration in the liver of Wister rats, according to the findings in this study.

Newly synthesized chitosan-stevioside-TPGS nanoparticles (CSdNPs) attenuate the effects of high doses of free stevioside in male rats via inhibition of PRAP-α gene expression

This study investigated newly synthesized of chitosan-St-TPGS-NPs and chitosan-Sd-TPGS-NPs (CStNPs and CSdNPs) produced by a combination of sonication and emulsification/solvent evaporation method and in combination with the ionic gelation method with slight modifications. The newly synthesized CStNPs and CSdNPs were characterized by several technical methods such as SEM, TEM and FT-IR. In this study, 60 male Wistar rats were divided randomly into six groups. Each group included 10 animals with control group, stevia group (St), stevioside group (Sd), CNPs group, chitosan-stevia-TPGS nanoparticles (CStNPs) group, chitosan-stevioside-TPGS nanoparticles (CSdNPs) group. All the groups received their daily dosages orally for two months. After the end of the experiment, a blood sample was collected for estimation of the liver enzyme concentration (ALT, AST, ALP, and TSB), lipids profile (TC, TG, LDL-C, VLDL-C, and HDL-C), hematological parameters (RBCs, WBCs, Hb, and PCV, also FAS, FBG, and TyG index). Analysis was performed to assess the average change (AFC) in PPAR-α gene expression in all study groups. The results suggested that there is a significant difference in FAS (pg/mL) levels between the control group (494.2 ± 15.8) and the St or free Sd groups at the end of 2nd month (511.6 ± 16.2, and 561.7 ± 17.2), respectively. In addition the highly significant differences were registered between the Sd group in comparison with CNPs, CStNPs, and CSdNPs groups at the end of the experiment. On the other hand, the results of this study suggested that there is a significant difference in AFC between the control group (5.86 ± 0.58) and St or free Sd groups at the end of the 2nd month (3.00 ± 0.22, and 1.86 ± 0.12), respectively. In addition, highly significant differences were found between the Sd group (1.86 ± 0.12) and the CNPs, CStNPs, and CSdNPs groups at the end of the experiment (4.98 ± 0.25, 3.91 ± 0.24, and 4.02 ± 0.45). This study concluded that St and in large form Sd have harmful effects on the male liver of male rats. The newly synthesized (CStNPs and CSdNPs) should attenuate the risk of St and Sd via the activation of PPAR-α gene expression and inhibition of FAS.

COVID-19-Related Cholangiopathy: Histological Findings.

We subjected post-COVID-19 cholestasis liver samples to routine staining techniques and cytokeratin 7 immunostaining and semi-quantitatively analyzed the portal and parenchymal changes. All ten patients, five men, had a median age of 56, an interquartile range (IQR) of 51-60, and required intensive care unit and mechanical ventilation. The median and IQR liver enzyme concentrations proximal to biopsy were in IU/L: ALP 645 (390-1256); GGT 925 (664-2169); ALT 100 (86-113); AST 87 (68-106); and bilirubin 4 (1-9) mg/dL. Imaging revealed intrahepatic bile duct anomalies and biliary casts. We performed biopsies at a median of 203 (150-249) days after molecular confirmation of infection. We found portal and periportal fibrosis, moderate-to-severe ductular proliferation, and bile duct dystrophy in all patients, while we observed hepatocyte biliary metaplasia in all tested cases. We observed mild-to-severe parenchymal cholestasis and bile plugs in nine and six cases. We also observed mild swelling of the arteriolar endothelial cells in five patients. We observed a thrombus in a small portal vein branch and mild periductal fibrosis in one case each. One patient developed multiple small biliary infarctions. We did not observe ductopenia in any patient. The alterations were like those observed in SSC-CIP; however, pronounced swelling of endothelial cells, necrosis of the vessel walls, and thrombosis in small vessels were notable.

Comparative effects of dietary muramidase and phytogenics on the growth performance and gastrointestinal functionality of broiler chickens

The objective of the present study was to compare the effectiveness of dietary supplementation of muramidase (MUR) and 2 phytogenic additives on the growth performance, intestinal morphology, bacteria load, and production of short-chain fatty acids (SCFA) of broiler chickens raised under field-like conditions. A total of 6,400 day-old Ross 308 broiler chicks were randomly selected and distributed into 32 floor pens, with 200 chicks (100 males and 100 females)/pen. The treatment groups were an unsupplemented control, and the experimental groups supplemented with MUR at 35,000 LSU(F)/kg of feed, phytogenic 1 (Phyto 1, based on thymol) at 100g/ton feed, or phytogenic 2 (Phyto 2, based on alkaloids) at 60g/ton feed, for a total period of 41 d. A 4-phase feeding program was applied (starter, grower, finisher and withdrawal). The paramenters evaluated were: growth performance, carcass yield, concentration of muranic acid in the jejunum content and excreta, liver enzyme concentration, intestinal morphology, and bacteria enumeration and short and branch chain fatty acids (SCFA and BCFA) in the cecal content. Data were analyzed by ANOVA and Tukey's test was used to separate the means. Soluble muramic acid (MurN) in the jejunum increased with the supplementation of MUR and Phyto 2 when compared to the other groups (P = 0.0001), but only the supplementation of MUR increased the concentration of MurN in the excreta. The supplementation of all feed additives improved the body weight gain and the body weight corrected feed conversion ratio when compared to the control group (P = 0.0001). MUR increased villus heigh (VH) when compared to the control or the other supplemented groups (P = 0.0001), and led to the highest concentration of most SCFA, total BCFA, and total SCFA (P < 0.05). In conclusion, the supplementation of MUR and phytogenics to the diets of broiler chickens improved the growth performance, but MUR, only, was capable of effectively degrading peptidoglycans (PGNs) in both intestinal segments, as well as to increase the abundance of beneficial bacteria and SCFA production.

The injection of maternal B complex vitamin during the transition period: The impact on performance, thyroid hormones levels and immunological parameters in the Sannen goats and their kids, as well as the faeces status of newborn kids.

It is proven that B vitamins through promote a wide range of metabolic pathways in animals as cofactors improve animal performance. This study was conducted to investigate the impacts of maternal B complex vitamin injection on performance and plasma parameters in goats and their offspring, as well as the faeces status of newborn kids. In this research, the pregnant goats (3 years old) were randomly divided into two groups: the control group (without B complex vitamin injection) and the B complex vitamin group (5mL B complex vitamin injection per animal). The animals were injected with 5mL B complex vitamin twice during the transition period (5 weeks pre- and 5 weeks post-kidding). The goats during the transition period and kids on days 10, 20 and 30 were weighed. Feed intake by goats and consumption of milk and starter in kids were recorded daily. The dry matter digestibility by kids was tested by collecting samples of faeces and feed for 5 days in the last week. Chemical analysis was determined using the AOAC method. The kids' faeces were prepared daily during the study. The blood samples of goats and newborn kids were taken 7 days after kidding. Then, levels of B group vitamin, as well as concentrations of liver enzymes, thyroid hormones and immunological parameters, were determined in plasma of goat and their offspring. In addition, concentrations of glucose and insulin were measured in goat plasma (Asadi et al., 2024). According to results, the performances of goats and their offspring, as well as kids' faeces status, were improved by maternal B complex vitamin injection (p<0.0001). The levels of cobalamin, pyridoxine, thiamine, folic acid, nicotinic, pantothenic and unconjugated pteridine increased in the plasma of goats and their kids in the B complex vitamin group compared with the control group during the transition period (p<0.0001). Injection of maternal B complex vitamin raised the plasma levels of triiodothyronine and tetraiodothyronine, immunoglobulin G and immunoglobulin M in goats and their offspring (p<0.0001). Higher levels of glucose and lower levels of insulin were determined in the goats injected with B complex vitamin (p<0.0001). These results suggest that maternal B complex vitamin injection is required for the improvement of performance, health status and the blood plasma parameters in pregnant goats and their kids.

Stimulatory Effects of Phyllanthus amarus Extract on the Growth Performance, Hematobiochemical Activity, Antioxidative Status and Immune Response of Clarias gariepinus

This study investigated the antibacterial activity of Phyllanthus amarus extracts and its influence on the performance of Clarias gariepinus fingerlings. The fish were fed diets containing 0.0, 0.5, 1.0, 1.5 or 2.0 g P. amarus methanol extract (PAE) / kg basal diet for 84 days. Thereafter, blood samples were collected for hematological and biochemical analyses. At the end of the 84-day feeding trial, fish were challenged with Aeromonas hydrophila, after which immune response parameters were measured. The data obtained were analyzed using one-way analysis of variance at p&lt;0.05. The results showed significant antibacterial activity of PAE against A. hydrophila, and its application at 0.5-1.5 g significantly promoted growth performance, with the highest at 1.0 g. Hematocrit, hemoglobin and lymphocytes were enhanced at 0.5-1.5 g PAE. All the fishes fed PAE-supplemented diets had lower concentrations of serum liver enzymes; while the values of creatinine, glucose and total bilirubin did not differ among the treatments. Glutathione peroxidase, glutathione‐S‐transferase, lysozyme, phagocytic and respiratory burst activities increased in all PAE-fortified treatments, with highest fish survival in 1.0 g PAE treatment. Therefore, the inclusion of 1.0 g Phyllanthus amarus extract is recommended as a dietary supplement for Clarias gariepinus.

Keeping patients in the dark: perioperative anesthetic considerations for patients receiving 5-aminolevulinic acid for glioma resection.

5-Aminolevulinic acid hydrochloride (5-ALA), available under the trade name Gleolan, is an orally administered fluorophore drug used to enhance visual differentiation of cancerous tissue from healthy tissue, primarily during surgical resection of high-grade gliomas. Although given preoperatively, 5-ALA has important implications for anesthetic care throughout the perioperative period. This article reviews pharmacology, safety concerns, and perioperative considerations for patients who receive oral 5-ALA. Although approved for clinical use by the United States Food and Drug Administration in 2017, studies and case reports published since then have further delineated side effects of this medication and its mechanisms and pharmacokinetics. Mitigating the possible side effects of 5-ALA requires an understanding of its basic mechanism as well as focused perioperative planning and communication. Administration of this medication may result in nausea, vomiting, photosensitivity, increase in serum concentration of liver enzymes, and hypotension. Patients who receive 5-ALA must be protected from prolonged light exposure during the first 48 h after consumption and administration of other photosensitizing agents should be avoided (Supplemental Video File/Video abstract).

Green Synthesis of Zinc Oxide Nanoparticles Using Currant Extracts and Study of Protective against Liver Necrosis of Rat

Abstract Aim: The goal of the current research was to synthesize zinc oxide nanoparticles (ZnONPs) via a simple, cheap, and eco-friendly method as an efficient antioxidant agent. Materials and Methods: ZnONPs are synthesized by reduction of zinc acetate dehydrate using extract of black currant (BC) as reductant. The characterization of stability, size, morphology, and the surface function groups present on synthesized ZnOBCNPs was achieved by Fourier transform infra red, scanning electron microscopy, and X-ray diffraction. In addition, the research included investigating the protective effect of prepared ZONPS on oxidative-stressed rats and evaluating its effectiveness in reducing free radical-induced damage by tracking the concentrations of liver enzymes and blood lipid profiles of rats. Results: The results showed that ZONPS has a positive, beneficial effect in the protection of the rat tissues and ameliorating side effects of oxidative stress. Conclusions: ZONPS can be produced in a simple way, quickly, and in an environmentally friendly manner without the use of hazardous reagents. In this method, zinc acetate dehydrate is reduced with an aqueous solution of BC. The ZONPS, thus produced, can be used as a tissue protectant against oxidative stress. The results showed that the concentrations of liver enzymes and blood lipid profile were stable within normal values in rats exposed to oxidative stress and treated with the prepared ZONPS solution. This indicates that the prepared nanoparticles reduced the harmful effect of oxidative stress through several proposed mechanisms mentioned previously.

Potential Activity of Micafungin and Amphotericin B Co-Encapsulated in Nanoemulsion against Systemic Candida auris Infection in a Mice Model.

The Candida auris species is a multidrug-resistant yeast capable of causing systemic and lethal infections. Its virulence and increase in outbreaks are a global concern, especially in hospitals where outbreaks are more recurrent. In many cases, monotherapy is not effective, and drug combinations are opted for. However, resistance to antifungals has increased over the years. In view of this, nanoemulsions (NEs) may represent a nanotechnology strategy in the development of new therapeutic alternatives. Therefore, this study developed a co-encapsulated nanoemulsion with amphotericin B (AmB) and micafungin (MICA) (NEMA) for the control of infections caused by C. auris. NEs were developed in previous studies. Briefly, the NEs were composed of a mixture of 10% sunflower oil and cholesterol as the oil phase (5:1), 10% Polyoxyethylene (20) cetyl ether (Brij® 58) and soy phosphatidylcholine as surfactant/co-surfactant (2:1), and 80% PBS as the aqueous phase. The in vivo assay used BALB/c mice weighing between 25 and 28 g that were immunosuppressed (CEUA/FCF/CAr n° 29/2021) and infected with Candida auris CDC B11903. The in vivo results show the surprising potentiate of the antifungal activity of the co-encapsulated drugs in NE, preventing yeast from causing infection in the lung and thymus. Biochemical assays showed a higher concentration of liver and kidney enzymes under treatment with AmB and MICAmB. In conclusion, this combination of drugs to combat the infection caused by C. auris can be considered an efficient therapeutic option, and nanoemulsions contribute to therapeutic potentiate, proving to be a promising new alternative.

Effects of Feeding Glucogenic and Lipogenic Diets on Performance and Blood Parameters of Transition Dairy Cows and Their Calves

Introduction: Several studies have explored the impact of diet type on energy sources. The current study aimed to evaluate the impact of feeding glucogenic versus lipogenic diets to Holstein dairy cows during the close-up period on cows' performances and their calves' growth parameters. Materials and methods: Twenty-four Holstein dairy cows with an average parity of 3 selected for the study, starting 21 days before expected calving. The cows were divided into three groups based on a randomized complete block design including a Control diet (glucogenic diet, Glu), a low lipogenic diet (Llip) with 25% barley grain replaced by beet pulp, and a high lipogenic diet (Hlip) with 50% barley grain replaced by beet pulp. Daily recording of dry matter intake (DMI) was conducted, with blood samples collected on the day of parturition in cows and days 1, 2, 7, and 21 of calves age. In dairy cows, both the quality and quantity of colostrum were determined. Additionally, performance variables including feed intake, average daily gain, and skeletal parameters such as shoulder height, Hip height, and body length were measured. Blood parameters, such as glucose, triglyceride, and concentrations of certain liver enzymes, including alkaline phosphatase (ALP), serum glutamic-pyruvic transaminase (SGPT), and serum glutamate oxaloacetate transaminase (SGOT) were recorded in calves. Results: The increase of beet pulp in the prepartum diet led to a significant increase in DMI. Colostrum yield and constituents (protein, lactose, and solids nonfat percentage) decreased with an increase in beet pulp level and the differences between Glu and Hlip were significant. Performance parameters of the calves were similar across all treatments, except skeletal growth. Calves that were fed the Hlip diet showed a lower shoulder height compared to those fed the Glu diet. Blood glucose was significantly higher in cows and their offspring that were fed Llip diets compared to other groups. The concentration of liver enzymes, including ALP, SGPT, and SGOT was not affected by treatments. Conclusion: Substituting barley grain with beet pulp as a lipogenic component may enhance dry matter intake in periparturient dairy cows. However, it did not show a notable impact on offspring performance.

Effect of oral dosage of Spirulina platensis and silver nanoparticles on glucose, lipid profile, and liver enzymes in male rats induced di-abetics by alloxan

Diabetes is believed to be one of the most important challenges that are facing societies around the world. The research was conducted to determine the effectiveness of 150 mg/ml of Spirulina platensis and 10 mg/ml of silver nanoparticles Ag-NPs on the sugar level, lipid profile, and liver enzyme concentration in male rats. Diabetes was induced with alloxan and bred for four weeks. The rats were divided randomly into five groups and every single group contained five rats; M1 was the control group, M2 was a treated diabetic rat, M3 treated diabetic rats with 10 mg/ml Ag-NPs, M4 treated diabetic rats with 150 mg/ml S. platensis and M5 group with diabetic rats that were treated with 10 mg/ml Ag-NPs + 150 mg/ml S. platensis. The results showed that the group of rats infected with Alloxan (M2) caused negative effects at a significant level (P&lt;0.05) on the blood sugar level, while the group of rats treated with Ag-NPs (M3) or S. platensis (M4) or both (M5) showed a positive effect on the blood glucose rate, which reached 292.6, 210.5, and 199.3 mg/dl, respectively, compared to the (M2) group, which was 441.8 mg/dl. The results of the lipids profile, the group with diabetes (M2) showed an increase in the level of triglycerides (TG), cholesterol (TC), low-density lipoproteins (LDL), and very low-density lipoproteins (VLDL), and a decrease in the level of high-density lipoproteins (HDL). The treatment groups M3, M4, and M5 improved significantly positive blood lipid levels. The same situation applied to the liver enzymes AST, ALT, and ALP, whose values decreased significantly in the treatment groups (M3, M4, and M5) compared to the infection group (M2).&#x0D;

Efficacy of Paromomycin-Conjugated Nano Chitosan in Treating Entamoeba histolytica Infection in Mice

Entamoeba histolytica is an intestinal parasite that causes amebiasis, a disease widespread in developing countries. This parasite primarily attacks the colon, producing ulceration of the colon's intestinal epithelial cells; nevertheless, the infection can spread to the liver, resulting in liver abscesses. The present study aimed to investigate treatment solutions for amebiasis. The chitosan nanoparticles were synthesized using the Ultrasonic method, and the antibiotic paromomycin was conjugated with the nanoparticles. seventy Swiss albino male mice infected with E. histolytica were treated with antibiotic-loaded nanoparticles, and the response to treatment was evaluated using liver enzymes (Alkaline phosphatase (ALP), Alanine transaminase (ALT), and Aspartate transaminase (AST). The study's findings revealed that The AST, ALT, and ALP activities increased significantly in the infected untreated group as they were 102.84±8.89, 104.06 ±7.50, and 533.41±21.18 (U/L) for AST, ALT, and ALP respectively; as for the groups that were infected and treated, they showed an improvement and a significant decrease in the concentration of liver enzymes for all treatments. The treatment of infected mice with 75% nano chitosan + 25% paromomycin showed the best therapeutic effect concerning AST and ALP as it minimized the levels of these enzymes as (62.12± 9.46) and (439.4527.43) (U/L) respectively, while for ALT enzyme, the highest significant therapeutic effect was observed in the group that treated with Nano-chitosan only (63.46±8.06) (U/L). The present study represented the efficiency of the prepared nanomaterial in conjugating with the antibiotic in treating mice infected with the parasite, as this was observed through a decrease in the concentrations of the three liver enzymes.